Back to News
Market Impact: 0.15
THNR's Weight-Loss Index Swaps Hims & Hers for Gilead
Source: etftrends.com
Healthcare & BiotechMarket Technicals & Flows
Amplify Weight Loss Drug & Treatment ETF (THNR) refreshed its holdings following a scheduled Sept. rebalancing of its underlying VettaFi Weight Loss Drug & Treatment Index (THINR). The update reflects ongoing changes in the competitive landscape for weight-loss drug developers and treatment providers, but the article provides no specific constituent changes, weights, or performance figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
More News
- AI’s Grip on Financial Markets Was Never Clearer on the Way Down
- Tech stock rout, driven by US AI fears, continues in Asian trading
- Asian Markets Tally Losses From Worsening Global Rout
- Magnificent 7 loses $1 trillion. The most eye-popping stats from Thursday's tech stock plunge
- Wall Street’s best post-midterm rally in 44 years lasted just one day—then $3 trillion vanished as chip stocks plunged over AI fears
- How Wall Street's postelection rally got obliterated — and what's next